Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children
- PMID: 3025356
- DOI: 10.1002/jmv.1890210106
Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children
Abstract
The preexisting levels of rotavirus IgA and IgG were measured in 225 children aged 6 months to 7 years in November, ie, before the "rotavirus season" from January to April. During the following 6 months, all episodes of acute gastroenteritis (GE) were evaluated clinically according to a score system and feces was examined for rotavirus, pathogenic bacteria, and parasites. Furthermore, rotavirus GE (n = 45) as well as asymptomatic rotavirus infections (n = 29) were diagnosed serologically. The preexisting concentrations of rotavirus IgA and IgG measured by ELISA were similar in these two groups. However, preexisting rotavirus IgA in the group of children who developed rotavirus GE correlated with less severe symptoms. Thus vomiting was found in 24% and 63% of the children with detectable and undetectable rotavirus IgA, respectively (P less than 0.025). Moreover, according to the total symptom score of rotavirus GE, 52% of the children with detectable preexisting rotavirus IgA had mild symptoms compared with only 13% of those with undetectable concentrations (P less than 0.025). Rotavirus IgG did not have any protective effect. Age per se had a protective effect; older age (greater than 1.5 years) was related to mild symptoms. According to previous studies of local and intestinal antibody response to a rotavirus GE, it is suggested that rotavirus IgA in serum reflects the immunological status of the intestine concerning rotavirus. It is recommended that studies of rotavirus vaccines include rotavirus IgA response and its protective effect.
Similar articles
-
Antibody response in serum and intestine in children up to six months after a naturally acquired rotavirus gastroenteritis.J Pediatr Gastroenterol Nutr. 1986 Jan;5(1):74-80. doi: 10.1097/00005176-198601000-00014. J Pediatr Gastroenterol Nutr. 1986. PMID: 3944746
-
Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.J Med Virol. 2002 Sep;68(1):119-28. doi: 10.1002/jmv.10178. J Med Virol. 2002. PMID: 12210439
-
Serum antibody as a marker of protection against natural rotavirus infection and disease.J Infect Dis. 2000 Dec;182(6):1602-9. doi: 10.1086/317619. Epub 2000 Oct 23. J Infect Dis. 2000. PMID: 11069230
-
Correlates of protection against rotavirus infection and disease.Novartis Found Symp. 2001;238:106-13; discussion 114-24. doi: 10.1002/0470846534.ch8. Novartis Found Symp. 2001. PMID: 11444023 Review.
-
Live attenuated human rotavirus vaccine, Rotarix.Semin Pediatr Infect Dis. 2006 Oct;17(4):188-94. doi: 10.1053/j.spid.2006.08.006. Semin Pediatr Infect Dis. 2006. PMID: 17055369 Review.
Cited by
-
Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection.Clin Diagn Lab Immunol. 2005 Oct;12(10):1157-63. doi: 10.1128/CDLI.12.10.1157-1163.2005. Clin Diagn Lab Immunol. 2005. PMID: 16210477 Free PMC article.
-
Malnutrition Decreases Antibody Secreting Cell Numbers Induced by an Oral Attenuated Human Rotavirus Vaccine in a Human Infant Fecal Microbiota Transplanted Gnotobiotic Pig Model.Front Immunol. 2020 Feb 14;11:196. doi: 10.3389/fimmu.2020.00196. eCollection 2020. Front Immunol. 2020. PMID: 32117313 Free PMC article.
-
Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.Hum Vaccin Immunother. 2014;10(2):505-11. doi: 10.4161/hv.27097. Epub 2013 Nov 13. Hum Vaccin Immunother. 2014. PMID: 24240068 Free PMC article. Clinical Trial.
-
Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.AIDS. 2017 Jan 2;31(1):49-59. doi: 10.1097/QAD.0000000000001258. AIDS. 2017. PMID: 27662551 Free PMC article. Clinical Trial.
-
Immunology of gut mucosal vaccines.Immunol Rev. 2011 Jan;239(1):125-48. doi: 10.1111/j.1600-065X.2010.00970.x. Immunol Rev. 2011. PMID: 21198669 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous